Abstract:Aim . To determine the correlation between the results of the 6-minute walk test (6MWT) and peak oxygen consumption (VO 2peak ) for populations of patients with chronic heart failure with pronounced clinical and demographic differences; to study a possibility of indirect measurement of VO 2peak based on the results of 6MWT using the formulas available from the literature. Material and methods . Two databases were analyzed: 50 patients included in the AEROFIT study (group A), and 31 patients from the Almazov National Medical Research Center (group B). The inclusion criteria were the availability of data from the cardiopulmonary stress test and the 6MWT. The possibility of predicting VO 2peak was calculated based on the results of 6MWT using the formulas reported in the literature (L. P. Cahalin et al., 1996; R. M. Ross et al., 2010; R. A. Adedoyin et al., 2010). The predictive accuracy of the models was assessed using the coefficient of determination (R 2 ). The relationship between functional and clinical-demographic indicators was assessed using the Pearson or Spearman correlation analysis. Results . The study groups differed significantly in all parameters, except for the proportion of men and the mean VO 2peak . Group B patients were 20 years younger than group A patients, had a lower left ventricular ejection fraction (24.06±7.75 and 41.52±10.48 %, respectively; p<0.001), and covered a 130 m shorter distance in the 6MWT. Despite the absence of a significant difference in VO 2peak between groups A and B (13.6 and 13.1 ml / kg / min, respectively; p=0.6581), 61 % of group B patients and 20% of group A belonged to Weber functional class IV. In group A, the 6MWT distance correlated closely with VO 2peak (R=0.78; p<0.01) and weakly with age (R=0.4) and body mass index (R=0.3). In group B, the 6MWT distance correlated only with VO 2peak (R=0.77; p<0.01). For group A, the R.M. Ross et al. model demonstrated high accuracy in determining the mean VO 2peak value with a 0.06% prediction error normalized to measured VO 2peak . For group B, none of the models showed satisfactory predictive accuracy. The Ross and Cahalin models showed the best coefficients of determination for groups A and B: Group A, Ross et al. (R 2 =0.58) and Cahalin et al. (R 2 =0.59); Group B, Ross et al. (R 2 =0.59) and Cahalin et al. (R 2 =0.6). Conclusion . In two groups of patients with a statistically insignificant difference in the mean values of VO 2peak , the mean values of 6MWT distance were significantly different, although these indicators correlated closely. The VO 2peak prediction models showed satisfactory accuracy for estimation of mean VO 2 , but poor accuracy for estimation of individual values. A better predictive accuracy is determined by similar clinical and demographic characteristics between the training and testing populations, and likely also by models based on larger, more diversified populations.

Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure

Functional limitation predicts mortality in heart failure with preserved ejection fraction

Determinants and reference values of the 6-min walk distance in the general population—results of the population-based STAAB cohort study

Differences in 6-Minute Walk Distance Across Heart Disease Recurrence Risk Levels in Cardiac Rehab Patients

Prognostic Value of Borg Scale Following Six-minute Walk Test in Hospitalized Older Patients with Heart Failure

Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure

Effect Of Therapies On 6-minute Walk Distance In Heart Failure With Reduced Ejection Fraction: A Systematic Review And Meta-analysis

Relationship between six-minute walk distance and cardiopulmonary exercise testing in non-obstructive hypertrophic cardiomyopathy

Physical health status measures predict all-cause mortality in patients with heart failure

Establishment of Exercise Intensity for Patients with Chronic Heart Failure Equivalent to Anaerobic Threshold Based on 6-Minute Walking Test.

Autonomic Nerve Function Predicts Risk of Early Death after Discharge in Acute Medical Disease

Six‐minute Walk Test Predicts All‐cause Mortality and Technique Failure in Ambulatory Peritoneal Dialysis Patients

Possibilities of Predicting Peak Oxygen Consumption in Patients With Chronic Heart Failure According to the 6‐Minute Walk Test

One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis

An association between heart rate variability and incident heart failure in an elderly cohort

Prognostic Impact Of Baseline Six-minute Walk Distance In Patients Receiving TAVR

Incremental prognostic value of functional impairment assessed by 6-min walking test for the prediction of mortality in heart failure

Analysis of Factors Associated with 6MWD among Older Patients with Chronic Heart Failure

Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure

Six-minute walk distance in healthy young adults.

Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors